Inventor · disambiguated record
Dinara Gunasekera
Also filed as: GUNASEKERA DINARA · GUNASEKERA DINARA S · GUNASEKERA DINARA SHASHANKA
5 granted patents·9 pending applications·3 citations·filing 2019–2025
67Inventor score
Files withFLAGSHIP PIONEERING INNOVATIONS V INC8NEW FRONTIER BIO INC2RESOLUTE BIO INC2DARBIX LLC1SAIL BIOMEDICINES1
Top patents by PatentIndex Score
14 records- 0190US10953027B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Mar 23, 2021·3 cites·9 claims
- 0274US2024180941A1Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2023·Application pending·0 cites
- 0372US12115178B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Oct 15, 2024·0 cites·9 claims
- 0468US11813272B2Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver diseaseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Nov 14, 2023·0 cites·9 claims
- 0568US2024254186A1GLP-1 Receptor Agonists Having Improved Pharmacological and Drug Delivery PropertiesDARBIX LLC·Filed 2023·Application pending·0 cites
- 0665US11058698B2Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Granted Jul 13, 2021·0 cites·2 claims
- 0764US2021283157A1Acylated active agents and methods of their use for the treatment of autoimmune disordersFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 0861US2023015478A1Glp-1 receptor agonists having improved pharmacological and drug delivery propertiesRESOLUTE BIO INC·Filed 2022·Application pending·0 cites
- 0960US2023173086A1Peptide conjugates and therapeutic agents having improved pharmacological and pharmacokinetic propertiesRESOLUTE BIO INC·Filed 2022·Application pending·0 cites
- 1059US2025295624A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2025·Application pending·0 cites
- 1159US2021299079A1Monomethyl fumarate-carrier conjugates and methods of their useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Application pending·0 cites
- 1259US2023242558A1Nicotinate and nicotinamide riboside-based compounds and derivatives thereofNEW FRONTIER BIO INC·Filed 2023·Application pending·0 cites
- 1348US2025313552A1Nicotinate esters and therapeutic methods of use thereofNEW FRONTIER BIO INC·Filed 2025·Application pending·0 cites
- 1446US12162902B2Decarboxylase inhibitors for treating Parkinson's diseaseSAIL BIOMEDICINES·Filed 2019·Granted Dec 10, 2024·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →